The University of Chicago Header Logo

Connection

Anjana Pillai to Liver Transplantation

This is a "connection" page, showing publications Anjana Pillai has written about Liver Transplantation.
Connection Strength

8.307
  1. Geographic opportunities for growth in the transplant hepatology training workforce. Liver Transpl. 2024 Oct 01; 30(10):1091-1094.
    View in: PubMed
    Score: 0.551
  2. Evolving challenges with long-term care of liver transplant recipients. Clin Transplant. 2023 10; 37(10):e15085.
    View in: PubMed
    Score: 0.524
  3. Many transplant hepatology graduates feel unprepared for first job search: Results from a national employment survey of early career hepatologists. Liver Transpl. 2023 12 01; 29(12):1332-1336.
    View in: PubMed
    Score: 0.519
  4. CAQ Corner: Evaluation and management of living liver donors. Liver Transpl. 2023 10 01; 29(10):1118-1128.
    View in: PubMed
    Score: 0.517
  5. Perspective: Advances in liver transplantation for hepatocellular carcinoma - A prototype for transplant oncology. Hepatobiliary Pancreat Dis Int. 2023 02; 22(1):4-6.
    View in: PubMed
    Score: 0.492
  6. Coagulopathy and hemostasis management in patients undergoing liver transplantation: Defining a dynamic spectrum across phases of care. Liver Transpl. 2022 10; 28(10):1651-1663.
    View in: PubMed
    Score: 0.481
  7. The New Era of Liver Transplantation for Cholangiocarcinoma: No Longer Just a 1-Man Show. Liver Transpl. 2022 03; 28(3):355-356.
    View in: PubMed
    Score: 0.468
  8. The effect of COVID-19 on liver transplantation: impact, practice patterns, therapeutics, and next steps. Curr Opin Organ Transplant. 2021 06 01; 26(3):339-345.
    View in: PubMed
    Score: 0.451
  9. Positron Emission Tomography With Computed Tomography as a Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma: Ready for Prime Time? Liver Transpl. 2020 06; 26(6):746-747.
    View in: PubMed
    Score: 0.418
  10. Mixed Hepatocellular-Cholangiocarcinoma: Is It Time to Rethink Consideration for Liver Transplantation? Liver Transpl. 2018 10; 24(10):1329-1330.
    View in: PubMed
    Score: 0.375
  11. Treatment of HCV infection in liver transplant recipients with ledipasvir and sofosbuvir without ribavirin. Aliment Pharmacol Ther. 2017 06; 45(11):1427-1432.
    View in: PubMed
    Score: 0.338
  12. Management of de novo malignancies after liver transplantation. Transplant Rev (Orlando). 2015 Jan; 29(1):38-41.
    View in: PubMed
    Score: 0.287
  13. Factors associated with sustained virological response in liver transplant recipients with recurrent hepatitis C. Transplant Proc. 2010 Nov; 42(9):3647-51.
    View in: PubMed
    Score: 0.216
  14. Overview of immunosuppression in liver transplantation. World J Gastroenterol. 2009 Sep 14; 15(34):4225-33.
    View in: PubMed
    Score: 0.200
  15. Influence of Acuity Circles on Hepatocellular Carcinoma and the Interaction of Gender and Race in Liver Transplantation. Clin Transplant. 2024 Dec; 38(12):e70045.
    View in: PubMed
    Score: 0.144
  16. Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future. Hepatol Commun. 2024 06 01; 8(6).
    View in: PubMed
    Score: 0.139
  17. Considerations in gender-affirming hormone therapy in transgender and gender diverse patients undergoing liver transplantation. Am J Transplant. 2024 Sep; 24(9):1567-1572.
    View in: PubMed
    Score: 0.138
  18. Management of alcohol-associated liver disease and alcohol use disorder in liver transplant candidates and recipients: Challenges and opportunities. Liver Transpl. 2024 Aug 01; 30(8):848-861.
    View in: PubMed
    Score: 0.137
  19. Association between bridging therapy and posttransplant outcomes in patients with HCC within Milan criteria: A systematic review and meta-analysis. Liver Transpl. 2024 Jun 01; 30(6):595-606.
    View in: PubMed
    Score: 0.136
  20. Advances and innovations in living donor liver transplant techniques, matching and surgical training: Meeting report from the living donor liver transplant consensus conference. Clin Transplant. 2023 07; 37(7):e14968.
    View in: PubMed
    Score: 0.128
  21. Financial, policy, and ethical barriers to the expansion of living donor liver transplant: Meeting report from a living donor liver transplant consensus conference. Clin Transplant. 2023 07; 37(7):e14955.
    View in: PubMed
    Score: 0.128
  22. Living donor liver transplantation: A multi-disciplinary collaboration towards growth, consensus, and a change in culture. Clin Transplant. 2023 07; 37(7):e14953.
    View in: PubMed
    Score: 0.128
  23. A survey of transplant providers regarding attitudes, barriers, and facilitators to living donor liver transplantation in the United States. Clin Transplant. 2023 07; 37(7):e14967.
    View in: PubMed
    Score: 0.128
  24. Living donor liver transplant candidate and donor selection and engagement: Meeting report from the living donor liver transplant consensus conference. Clin Transplant. 2023 07; 37(7):e14954.
    View in: PubMed
    Score: 0.128
  25. Combined heart-liver transplantation practices survey in North America: Evaluation and organ listing practices. Liver Transpl. 2023 06 01; 29(6):591-597.
    View in: PubMed
    Score: 0.127
  26. Practice patterns of the medical evaluation of living liver donors in the United States. Liver Transpl. 2023 02 01; 29(2):164-171.
    View in: PubMed
    Score: 0.126
  27. Heterogeneity in Center Practices in Liver Transplantation for Alcohol-Associated Liver Disease in the United States. Am J Gastroenterol. 2022 09 01; 117(9):1530-1535.
    View in: PubMed
    Score: 0.122
  28. Living Donor Liver Transplantation in the United States: Evolution of Frequency, Outcomes, Center Volumes, and Factors Associated With Outcomes. Liver Transpl. 2021 07; 27(7):1019-1031.
    View in: PubMed
    Score: 0.113
  29. Locoregional Therapies for Hepatocellular Carcinoma: What Has Changed in the Past Ten Years? Clin Liver Dis. 2020 11; 24(4):681-700.
    View in: PubMed
    Score: 0.108
  30. Liver transplantation for alcoholic hepatitis in the United States: Excellent outcomes with profound temporal and geographic variation in frequency. Am J Transplant. 2021 03; 21(3):1039-1055.
    View in: PubMed
    Score: 0.107
  31. Liver transplantation for hepatocellular carcinoma: Management after the transplant. Am J Transplant. 2020 02; 20(2):333-347.
    View in: PubMed
    Score: 0.102
  32. Goals and targets for personalized therapy for HCC. Hepatol Int. 2019 Mar; 13(2):125-137.
    View in: PubMed
    Score: 0.095
  33. Liver Transplantation in the Obese Cirrhotic Patient. Transplantation. 2017 10; 101(10):2288-2296.
    View in: PubMed
    Score: 0.087
  34. Simeprevir and Sofosbuvir (SMV-SOF) for 12 Weeks for the Treatment of Chronic Hepatitis C Genotype 1 Infection: A Real World (Transplant) Hepatology Practice Experience. Am J Gastroenterol. 2016 Feb; 111(2):250-60.
    View in: PubMed
    Score: 0.078
  35. Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management. Am J Transplant. 2015 May; 15(5):1162-72.
    View in: PubMed
    Score: 0.073
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.